The effect of EGFR activation is the activation of the NF-κB pathway and the upregulation of key genes involved in the inflammatory response and oxidative stress, contributing to the pathogenesis of obesity-related renal injury. This evidence concerns the gene NFKB1 and obesity due to melanocortin 4 receptor deficiency.